Lonza Group AG (ETR:LO3)

Germany flag Germany · Delayed Price · Currency is EUR
643.80
+12.20 (1.93%)
At close: May 5, 2025
1.93%
Market Cap 44.76B
Revenue (ttm) 7.01B
Net Income (ttm) 677.91M
Shares Out n/a
EPS (ttm) 9.51
PE Ratio 66.03
Forward PE n/a
Dividend 4.00 (0.63%)
Ex-Dividend Date May 13, 2024
Volume 9
Average Volume 16
Open 643.20
Previous Close 631.60
Day's Range 643.20 - 643.80
52-Week Range 291.20 - 643.20
Beta n/a
RSI n/a
Earnings Date Jul 23, 2025

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substanc... [Read more]

Industry Other
Founded 1897
Employees 18,944
Stock Exchange Deutsche Börse Xetra
Ticker Symbol LO3
Full Company Profile

Financial Performance

In 2024, Lonza Group AG's revenue was 6.57 billion, a decrease of -2.13% compared to the previous year's 6.72 billion. Earnings were 636.00 million, a decrease of -2.75%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.